Equiloid InnovatorThis page contains information on Equiloid Innovator for veterinary use.
The information provided typically includes the following:
- Equiloid Innovator Indications
- Warnings and cautions for Equiloid Innovator
- Direction and dosage information for Equiloid Innovator
Equiloid InnovatorThis treatment applies to the following species:
Eastern & Western, Killed Virus
Equiloid Innovator Indications
For vaccination of healthy horses 10 months or age or older as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses, and tetanus.
Dosage and AdministrationHorses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.
Equiloid Innovator Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
For Veterinary Use Only
Remove serial number and expiration date label and place on the animal’s medical chart.
U.S. Vet. License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Equiloid Innovator information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-05-31